Nathan Treybeck
Stock Analyst at Wells Fargo
(2.54)
# 2,380
Out of 5,056 analysts
21
Total ratings
42.86%
Success rate
7.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Nathan Treybeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LMAT LeMaitre Vascular | Maintains: Equal-Weight | $97 → $93 | $86.99 | +6.91% | 2 | Nov 7, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Overweight | $58 → $51 | $29.08 | +75.38% | 9 | Nov 5, 2025 | |
| ITGR Integer Holdings | Downgrades: Equal-Weight | $132 → $80 | $67.10 | +19.23% | 4 | Oct 24, 2025 | |
| RMD ResMed | Initiates: Equal-Weight | $280 | $244.71 | +14.42% | 1 | Oct 13, 2025 | |
| IRTC iRhythm Technologies | Maintains: Overweight | $130 → $180 | $167.51 | +7.46% | 5 | Aug 1, 2025 |
LeMaitre Vascular
Nov 7, 2025
Maintains: Equal-Weight
Price Target: $97 → $93
Current: $86.99
Upside: +6.91%
PROCEPT BioRobotics
Nov 5, 2025
Maintains: Overweight
Price Target: $58 → $51
Current: $29.08
Upside: +75.38%
Integer Holdings
Oct 24, 2025
Downgrades: Equal-Weight
Price Target: $132 → $80
Current: $67.10
Upside: +19.23%
ResMed
Oct 13, 2025
Initiates: Equal-Weight
Price Target: $280
Current: $244.71
Upside: +14.42%
iRhythm Technologies
Aug 1, 2025
Maintains: Overweight
Price Target: $130 → $180
Current: $167.51
Upside: +7.46%